STOCK TITAN
  1. Home
  2. Sec-filings
  3. AGEN
  4. [SCHEDULE 13G/A] Agenus Inc. SEC Filing

[SCHEDULE 13G/A] Agenus Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock AGEN logo
Agenus

NASDAQ:AGEN

AGEN Rankings

#4658 Ranked by Market Cap
N/A Ranked by Dividends

AGEN Latest News

Sep 9, 2025
France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer
Sep 5, 2025
Agenus to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Aug 26, 2025
Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight
Aug 19, 2025
Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025
Aug 11, 2025
Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

AGEN Latest SEC Filings

Oct 6, 2025
[Form 4] AGENUS INC Insider Trading Activity
Oct 3, 2025
[Form 4] AGENUS INC Insider Trading Activity
Oct 3, 2025
[Form 4] AGENUS INC Insider Trading Activity
Sep 23, 2025
[8-K] AGENUS INC Reports Material Event
Sep 23, 2025
[8-K] AGENUS INC Reports Material Event

AGEN Stock Data

132.24M
31.31M
1.71%
30.11%
8.48%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
LEXINGTON